NASDAQ : IPX

IperionX Limited

$22.94 USD

-$0.32 (-1.38%)

Volume
204.35K
Average Volume
299.47K
Market Capitalization
$769.87M
P/E Ratio
-13.32
Dividend Yield
0.00%
Price Target
$46.50
Year High
$61.45
Year Low
$21.66
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.03
Company Overview

NASDAQ

Anastasios Arima

Industrial Materials

Basic Materials

IPX

28

US

USD

https://www.iperionx.com

704 461 8000

44916E100

0001898601

Liquidity Metrics

0.04

4.03

4.00

3.81

0.00

Sales & Valuation

-$

0.00

7.09

-58.08

-0.42

Profitability

-$1.2

-$35.35M

0.00%

0.00%

-35.30%

-27.41%

P/E Metrics

-13.32

0.28

0.28

Analyst Price Target & Rating

$46.50

$53.00

$40.00

Sell

2/5

3 Analysts

-50.67%

Poll Results

About IperionX Limited (NASDAQ:IPX) Stock

IperionX Limited primarily focuses on discovering and developing mineral resource sites. The company's geological surveys seek out valuable deposits, specifically targeting epithermal and replacement-style precious and base metals, alongside titanium, rare earth elements, silica sand, and zircon. It possesses complete ownership of the Milford project, which consists of 101 claims within Utah, United States. Additionally, IperionX fully controls the Titan project, an approximately 6,000-acre area located in Tennessee, United States. Established in 2017, the enterprise was initially known as Hyperion Metals Limited, subsequently changing its name to IperionX Limited in February 2022. Its corporate headquarters are based in Charlotte, North Carolina. ...

IperionX Announces Pricing of Public Offering of American Depositary Shares

2026-07-07 19:51:00

SOUTH BOSTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (“IperionX” or the “Company”) (Nasdaq:IPX; ASX:IPX) today announced the pricing of an underwritten public offering of 2,275,000 of its American Depositary Shares (“ADSs”), with each ADS representing 10 of its ordinary shares (“Public Offering”), at a price per ADS to the public of $21.98, for aggregate gross proceeds of approximately $50 million, before deducting underwriting discounts, commission and estimated offering expenses payable by the Company.

IperionX Completes Strategic Camden Acquisition - Unlocking Ultra-High-Grade Critical Minerals to Accelerate U.S. Supply Chain

2026-07-02 08:30:00

INVESTMENT HIGHLIGHTS Transformational asset integration & strategic scale: IperionX has successfully completed the acquisition of the Camden critical mineral, heavy rare earths, and infrastructure assets. Highly synergistic with the adjacent Titan Project in Tennessee, this acquisition materially consolidates and expands IperionX's landholding across the Big Sandy Critical Minerals Province.

IperionX Awarded Up to US$6.6M by OSW-SWIB to Scale U.S. Titanium Plate for Defense Applications

2026-07-01 08:30:00

IperionX awarded up to US$6.6 million by the Office of the Secretary of War – Submarine Workforce and Industrial Base program (OSW-SWIB) The award forms part of a larger, multi-organization program to scale production of high-performance titanium alloy products, including ballistic-grade titanium plate, for land and maritime defense platforms Funding will support expanded manufacturing capability for large-format military titanium components at IperionX's Titanium Manufacturing Campus in Virginia, strengthening U.S. capacity for mission-critical titanium products and critical-material supply chains IperionX will collaborate with the George H. W. Bush Combat Development Complex (BCDC) and the U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL) to accelerate product scale-up, validation, and transition pathways for defense and strategic industrial applications Alongside the OSW-SWIB award, IperionX has received an additional purchase order from the U.S. Army Ground Vehicle Systems Center to manufacture a range of titanium fasteners for the JLTV in support of U.S. Army and Marine Corps operational requirements SOUTH BOSTON, Va.

Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations

2026-06-29 03:00:00

MILAN and BRIDGEWATER, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Zambon and Amneal Pharmaceuticals today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson's disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/DDC inhibitor-based treatment regimens.

IperionX to Acquire Rights to Rare Earth and Critical Mineral Assets Adjacent to Titan Project

2026-06-15 08:30:00

SOUTH BOSTON, Va., June 15, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce it has entered into an agreement to acquire certain key assets associated with Covia Solutions LLC's Camden, Tennessee silica sand operation.

IperionX: Titan Definitive Feasibility Study (DFS) Presentation

2026-06-10 08:30:00

SOUTH BOSTON, Va., June 10, 2026 (GLOBE NEWSWIRE) --  IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to provide a link to the Titan Critical Mineral Project Definitive Feasibility Study (DFS) presentation.

IperionX Titan DFS Confirms High-Return U.S. Rare Earths and Critical Minerals Project

2026-06-04 08:00:00

U.S. Government supported Definitive Feasibility Study delivers US$813 million after-tax NPV8, 39% IRR and US$1.9 billion after-tax free cash flow from an initial 14-year mine plan producing heavy rare earth concentrate, titanium minerals and zircon in Tennessee, U.S.A. SOUTH BOSTON, Va.

U.S. Army Testing Shows Iperionx Titanium Fasteners Exceed Grade 8 Steel Torque-To-Yield Performance

2026-06-01 08:30:00

SOUTH BOSTON, Va., June 01, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) is pleased to announce positive titanium fastener test results from independent testing programs completed by the U.S. Army DEVCOM Ground Vehicle Systems Center (GVSC) and Westmoreland Mechanical Testing & Research (WMTR).

Frequently Asked Questions

What is the current IperionX Limited (IPX) stock price?

IperionX Limited(NASDAQ:IPX) stock price is $22.94 in the last trading session. During the trading session, IPX stock reached the peak price of $61.45 while $21.66 was the lowest point it dropped to. The percentage change in IPX stock occurred in the recent session was --1.38% while the dollar amount for the price change in IPX stock was -$0.32.

IPX's industry and sector of operation?

The NASDAQ listed IPX is part of Industrial Materials industry that operates in the broader Basic Materials sector.

Who are the executives of IPX?

David Landrith | Executive Vice President of Metals
Dominic Allen | Chief Commercial Officer
Harold Sears | Head of Advanced Manufacturing
Toby Edgcumbe Symonds | President & Chief Strategy Officer
Todd William Hannigan | Executive Chairman

How many employees does IPX have?

Number of IPX employees currently stands at 28. IPX operates from 129 West Trade Street, Charlotte, NC 28202, US.

Link for IPX official website?

Official Website of IPX is: https://www.iperionx.com

How do I contact IPX?

IPX could be contacted at phone #704 461 8000 and can also be accessed through its website. IPX operates from 129 West Trade Street, Charlotte, NC 28202, US.

How many shares of IPX are traded daily?

The average number of IPX shares traded daily for last 3 months was 299.47K.

What is the market cap of IPX currently?

The market value of IPX currently stands at $769.87M with its latest stock price at $22.94